• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[BMY - 28100的药代动力学研究(二)]

[Studies on the pharmacokinetics of BMY-28100 (II)].

作者信息

Nakanomyo H, Ishikawa K, Esumi Y, Takaichi M, Jin Y, Gunji S, Ishikawa H, Sonobe J

机构信息

Preclinical Research Laboratories, Bristol-Myers Research Institute, Ltd.

出版信息

Jpn J Antibiot. 1990 Jul;43(7):1325-34.

PMID:2232160
Abstract

Studies were done in rats on placental transfer and excretion into milk of 14C-BMY-28100 upon single oral administration. Studies on absorption, distribution and excretion of 14C-BMY-28100 were also done upon multiple dosing. 1. Fetal tissue concentration of the drug reached a maximum at 6 hours after dosing on day 18 of gestation. The highest concentration observed was only 0.56 microgram equiv./g in fetal kidney; The transfer of radioactivity into the fetus was low. Similar results were obtained from whole body autoradiograms performed in rats on day 12 and day 18 of gestation. 2. Concentrations of radioactivity in milk reached a maximum of 0.60 microgram equiv./ml at 1 hour after administration, and gradually decreased thereafter. The maximum concentration in milk was 10% of the plasma concentration measured at the same time. 3. In the multiple oral administration study, 24 hours blood levels of radioactivity rose progressively with each dose, and reached a level 3.8 times higher than that observed with single dosing by the final (21st) administration. Tissue concentrations were relatively high in aorta, kidney and large intestine as were found upon single administration. However, the ratios of these levels between multiple and single dosing were lower than those observed in blood; 1.7, 3.6 and 2.9 for aorta, kidney and large intestine, respectively. Urinary and fecal excretion were constant after the 2nd administration.

摘要

对大鼠进行了研究,以观察单次口服14C - BMY - 28100后其在胎盘的转运及向乳汁中的排泄情况。还进行了多次给药后14C - BMY - 28100的吸收、分布和排泄研究。1. 在妊娠第18天给药后6小时,胎儿组织中的药物浓度达到最高。在胎儿肾脏中观察到的最高浓度仅为0.56微克当量/克;放射性物质向胎儿的转运较低。在妊娠第12天和第18天对大鼠进行的全身放射自显影也得到了类似结果。2. 给药后1小时,乳汁中的放射性浓度最高达到0.60微克当量/毫升,此后逐渐下降。乳汁中的最高浓度是同一时间测得的血浆浓度的10%。3. 在多次口服给药研究中,每次给药后24小时的放射性血药浓度逐渐升高,在最后一次(第21次)给药时达到比单次给药时观察到的水平高3.8倍的水平。与单次给药时一样,主动脉、肾脏和大肠中的组织浓度相对较高。然而,多次给药与单次给药时这些组织浓度的比值低于血液中的比值;主动脉、肾脏和大肠的比值分别为1.7、3.6和2.9。第二次给药后,尿液和粪便排泄量保持恒定。

相似文献

1
[Studies on the pharmacokinetics of BMY-28100 (II)].[BMY - 28100的药代动力学研究(二)]
Jpn J Antibiot. 1990 Jul;43(7):1325-34.
2
[Studies on the pharmacokinetics of BMY-28100 (I)].
Jpn J Antibiot. 1990 Jul;43(7):1310-24.
3
Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.新型促甲状腺素释放激素类似物水合蒙特瑞林的药代动力学。第二篇通讯:单次静脉给药后在胎体和乳汁中的分布与转运以及对大鼠重复静脉给药后的药代动力学和酶诱导作用
Arzneimittelforschung. 1996 Feb;46(2):114-27.
4
Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 3rd communication: placental transfer and excretion into milk in rats.新型类维生素A 4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯甲酸的代谢与处置研究。第三次通讯:大鼠的胎盘转运及经乳汁排泄情况
Arzneimittelforschung. 1997 Feb;47(2):201-8.
5
Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.普卢利沙星的药代动力学。第二篇通讯:大鼠重复给药后药代动力学及对肝脏药物代谢酶活性的影响,以及单次给药后药物向胎儿和乳汁的转运
Arzneimittelforschung. 1997 Mar;47(3):285-92.
6
[Distribution, metabolism and excretion of 14C-MT-141 in rats. II. Distribution and excretion after multiple intravenous administration in male rats and after single intravenous administration in female rats].[大鼠体内14C-MT-141的分布、代谢及排泄。II. 雄性大鼠多次静脉给药及雌性大鼠单次静脉给药后的分布与排泄]
Jpn J Antibiot. 1984 May;37(5):938-49.
7
Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.新型认知增强剂NS - 105的药代动力学。第二次通讯:单次给药后在大鼠体内的分布及向胎儿和乳汁的转运,以及重复给药对大鼠药代动力学和肝脏药物代谢酶活性的影响
Arzneimittelforschung. 1999 Dec;49(12):977-85.
8
Pharmacokinetics of 4-acetylaminophenylacetic acid. 2nd communication: tissue accumulation and enzyme induction in rats after repeated administration, and placental and milk transfer after single dosing.
Arzneimittelforschung. 1990 Jul;40(7):806-10.
9
Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 2nd communication: tissue levels and enzyme activity in rats after repeated administration, and placental and milk transfer after single administration.
Arzneimittelforschung. 1997 Feb;47(2):160-8.
10
[Studies on absorption, distribution and excretion of 14C labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (14C-T-2588) in rats and mice].
Jpn J Antibiot. 1986 Apr;39(4):979-90.